0919 Shaking up the Night: PCD & Sleep-Related Movement Disorders

Roberto Cardona Quinones,Edicer Ramírez-Rivera,Edwin Alvarez-Torres,Saidy Salem Hernandez,Fabiola Guasp Reyes,Maria Rivera Criado,Noel Vargas-Perez,Wilfredo De Jesus-Rojas
DOI: https://doi.org/10.1093/sleep/zsae067.0919
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Primary Ciliary Dyskinesia (PCD) is a rare genetic condition characterized by oto-sino-pulmonary pathologic manifestations with multiple comorbidities, including sleep-related disorders. The literature on sleep movement disorders in PCD is limited, especially for Hispanics. This pilot study aims to assess the presence of sleep movement disorders and other comorbidities in patients with the RSPH4A PCD founder mutation [c.921 + 3_921 + 6delAAGT] in Puerto Rico. Our specific aim is to identify sleep-related movement disorders in PCD patients with the Puerto Rican founder mutation. Recognizing the importance of early diagnosis and prevention of PCD-related sleep disorders in pediatric and adult patients with PCD will help increase the knowledge of this condition and its comorbid manifestations. Methods We performed a prospective case series of fourteen PCD patients (n=15; seven pediatric and eight adults) at the Puerto Rico PCD Center and Neurosleep Sleep Laboratory in San Juan, Puerto Rico. Both pediatric and adult patients were interviewed for sleep disturbances and sleep-related movement during the night. Sleep questionnaires such as the Epworth Sleepiness Scale, and STOP-Bang (including the Pediatric Modified) were administered. Finally, polysomnography (PSG) was performed on every PCD patient to evaluate for sleep-related disorders. Results Our preliminary data showed that most patients with RSPH4A [c.921 + 3_921 + 6delAAGT] PCD founder mutation presented a high risk for sleep-related movement disorders or manifestations, including Sleep-Related Bruxism, Periodic Limb Movement of Sleep, Hypnagogic Foot Tremor, Rhythmic Movement Disorder. However, there were additional manifestations presented in both history-taking and PSG results such as Alpha-Delta Sleep, NREM Parasomnias, and others presented with Obstructive Sleep Apnea. Conclusion PCD is a rare genetic condition characterized by oto-sino-pulmonary pathologic manifestations with multiple comorbidities, including sleep-related disorders. The mechanism for the development of sleep-related movement disorders due to this ciliopathy is not well understood. Further research involving Multiple Sleep Latency Tests, Actigraphy, and additional comprehensive neurophysiologic testing and evaluation is needed to make an early diagnosis and prevent further clinical deterioration. Additional studies are needed in multicentric clinical trials to answer whether these sleep manifestations are related to a neurodevelopmental or neurodegenerative process due to this rare ciliopathy like PCD. Support (if any)
neurosciences,clinical neurology
What problem does this paper attempt to address?